Relationships Between Markers of Inflammation and Bone Density: Findings from the Hertfordshire Cohort Study

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2018 May 30

PMID 29808230

Citations 20

Authors

N R Fuggle

L D Westbury

H E Syddall

N A Duggal

S C Shaw

K Maslin

E M Dennison

J Lord

C Cooper

Affiliations

Soon will be listed here.

Abstract

Introduction: The aim of this study was to examine the association between indices of inflammation and BMD in a population-based cohort of older adults in the UK.

Methods: Analyses were based on a sample of 194 men and 171 women of the Hertfordshire Cohort Study (community-living, older adults). Dual energy X-ray absorptiometry (DXA) was performed at the lumbar spine and proximal femur at baseline and repeated at a median of 4.5 years (inter-quartile range 3.6 to 5.2). Inflammatory markers (CRP, TNF, IL-1β, IL-6, IL-8, IL-10, adiponectin and leptin) were ascertained at baseline using enzyme-linked immunosorbent assay (ELISA) techniques and Bio-Plex Pro Assays. Gender-adjusted linear regression was used to examine the associations between markers of inflammation and outcomes with and without adjustment for anthropometric and lifestyle factors.

Results: The mean (SD) ages at baseline were 64.4 (2.5) and 66.5 (2.7) years for men and women respectively. Higher levels of adiponectin and adiponectin to leptin ratios were each associated with lower baseline lumbar spine and femoral neck BMD in gender-adjusted (p < 0.01) and fully adjusted (p < 0.05) analyses. Lower levels of IL-10 and TNF were each associated with accelerated decline in lumbar spine BMD in both gender-adjusted (p ≤ 0.05) and fully adjusted (p < 0.05) analyses.

Conclusions: In a cohort of older adults, high levels of adiponectin and adiponectin to leptin ratios were both associated with lower BMD at the lumbar spine and femoral neck at baseline, and lower IL-10 was associated with accelerated decline in BMD at the lumbar spine. This adds weight to the theory that bone health can be influenced by changes in immune phenotype and alterations in adipokine homeostasis.

Citing Articles

Autophagy: regulating the seesaw of bone-fat balance.

Zhang B, Cui J, Zhang X, Pan Z, Du L, Ye R Front Cell Dev Biol. 2025; 13:1465092.

PMID: 40066259 PMC: 11891371. DOI: 10.3389/fcell.2025.1465092.

Association of caffeine intake and sleep duration with bone mineral density: a cross-sectional study from National Health and Nutrition Examination Survey between 2011 and 2018.

He Y, Zou W, Xiao F BMC Musculoskelet Disord. 2025; 26(1):43.

PMID: 39806321 PMC: 11726935. DOI: 10.1186/s12891-025-08300-z.

Multimorbidity and risk of adverse outcomes in the Hertfordshire Cohort Study: does sex matter?.

Westbury L, Rambukwella R, Pearse C, Ward K, Cooper C, Dennison E Aging Clin Exp Res. 2024; 36(1):218.

PMID: 39541012 PMC: 11564394. DOI: 10.1007/s40520-024-02874-9.

Prediction of Osteoporotic Hip Fracture Outcome: Comparative Accuracy of 27 Immune-Inflammatory-Metabolic Markers and Related Conceptual Issues.

Fisher A, Fisher L, Srikusalanukul W J Clin Med. 2024; 13(13).

PMID: 38999533 PMC: 11242639. DOI: 10.3390/jcm13133969.

Association between Dietary Inflammatory Index and Bone Mineral Density Changes among Pregnant Women: A Prospective Study in China.

Zhu X, Zhou Y, Wen Z, Ye W, Gao L, Xu Y Nutrients. 2024; 16(3).

PMID: 38337739 PMC: 10857122. DOI: 10.3390/nu16030455.

References

Haam J, Kim Y, Kim M, Koo H, Kim H, Kim H . A cross-sectional study of the association between adipokine levels and bone mineral density according to obesity and menopausal status in Korean women. J Bone Miner Metab. 2016; 35(6):642-648. DOI: 10.1007/s00774-016-0801-8. View

Hengartner N, Fiedler J, Ignatius A, Brenner R . IL-1β inhibits human osteoblast migration. Mol Med. 2013; 19:36-42. PMC: 3646095. DOI: 10.2119/molmed.2012.00058. View

Dawson A, Dennison E . Measuring the musculoskeletal aging phenotype. Maturitas. 2016; 93:13-17. PMC: 5061080. DOI: 10.1016/j.maturitas.2016.04.014. View

Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H . Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000; 275(3):768-75. DOI: 10.1006/bbrc.2000.3379. View

Pasco J, Kotowicz M, Henry M, Nicholson G, Spilsbury H, Box J . High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA. 2006; 296(11):1353-5. DOI: 10.1001/jama.296.11.1353. View

Schett G, Kiechl S, Weger S, Pederiva A, Mayr A, Petrangeli M . High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med. 2006; 166(22):2495-501. DOI: 10.1001/archinte.166.22.2495. View

Barbour K, Boudreau R, Danielson M, Youk A, Wactawski-Wende J, Greep N . Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res. 2012; 27(5):1167-76. PMC: 3361578. DOI: 10.1002/jbmr.1559. View

Zhang Q, Chen B, Yan F, Guo J, Zhu X, Ma S . Interleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases. Biomed Res Int. 2014; 2014:284836. PMC: 3947664. DOI: 10.1155/2014/284836. View

Harvey N, Dennison E, Cooper C . Osteoporosis: impact on health and economics. Nat Rev Rheumatol. 2010; 6(2):99-105. DOI: 10.1038/nrrheum.2009.260. View

10.

Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel M, Ziegler R . Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab. 2001; 86(5):2032-42. DOI: 10.1210/jcem.86.5.7445. View

11.

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

12.

Dresner-Pollak R, Gelb N, Rachmilewitz D, Karmeli F, Weinreb M . Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology. 2004; 127(3):792-801. DOI: 10.1053/j.gastro.2004.06.013. View

13.

Ishii S, Cauley J, Greendale G, Crandall C, Danielson M, Ouchi Y . C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res. 2013; 28(7):1688-98. PMC: 3880424. DOI: 10.1002/jbmr.1915. View

14.

Emberson J, Whincup P, Morris R, Walker M, Lowe G, Rumley A . Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil. 2004; 11(2):125-34. DOI: 10.1097/01.hjr.0000114967.39211.e5. View

15.

Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E . Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000; 908:244-54. DOI: 10.1111/j.1749-6632.2000.tb06651.x. View

16.

Barbour K, Lui L, Ensrud K, Hillier T, LeBlanc E, Ing S . Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res. 2014; 29(9):2057-64. PMC: 4336950. DOI: 10.1002/jbmr.2245. View

17.

Koh J, Khang Y, Jung C, Bae S, Kim D, Chung Y . Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int. 2005; 16(10):1263-71. DOI: 10.1007/s00198-005-1840-5. View

18.

Cole Z, Harvey N, Kim M, Ntani G, Robinson S, Inskip H . Increased fat mass is associated with increased bone size but reduced volumetric density in pre pubertal children. Bone. 2011; 50(2):562-7. PMC: 3678245. DOI: 10.1016/j.bone.2011.05.005. View

19.

Ganesan K, Teklehaimanot S, Tran T, Asuncion M, Norris K . Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc. 2005; 97(3):329-33. PMC: 2568626. View

20.

Park B, Han I, Lee H, Kim L, Kim S, Shin J . Association of interleukin 10 haplotype with low bone mineral density in Korean postmenopausal women. J Biochem Mol Biol. 2004; 37(6):691-9. DOI: 10.5483/bmbrep.2004.37.6.691. View